From past to future: bibliometric analysis of global research productivity on nomogram (2000–2021)
X Wang, J Lu, Z Song, Y Zhou, T Liu… - Frontiers in public …, 2022 - frontiersin.org
Background Nomogram, a visual clinical predictive model, provides a scientific basis for
clinical decision making. Herein, we investigated 20 years of nomogram research …
clinical decision making. Herein, we investigated 20 years of nomogram research …
N6‐methyladenosine‐modified FAM111A‐DT promotes hepatocellular carcinoma growth via epigenetically activating FAM111A
J Pu, Z Xu, Y Huang, J Nian, M Yang, Q Fang… - Cancer …, 2023 - Wiley Online Library
As an epitranscriptomic modulation manner, N6‐methyladenosine (m6A) modification plays
important roles in various diseases, including hepatocellular carcinoma (HCC). m6A …
important roles in various diseases, including hepatocellular carcinoma (HCC). m6A …
[HTML][HTML] Non-coding RNA-Mediated N6-Methyladenosine (m6A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and …
The emergence of RNA modifications has recently been considered as critical post-
transcriptional regulations which governed gene expression. N 6-methyladenosine (m 6 A) …
transcriptional regulations which governed gene expression. N 6-methyladenosine (m 6 A) …
Comprehensive landscape of m6A regulator-related gene patterns and tumor microenvironment infiltration characterization in gastric cancer
B Peng, Y Lin, G Yi, M Lin, Y Xiao, Y Qiu, W Yao… - Scientific Reports, 2024 - nature.com
The epigenetic regulation of N6-methyladenosine (m6A) has attracted considerable interest
in tumor research, but the potential roles of m6A regulator-related genes, remain largely …
in tumor research, but the potential roles of m6A regulator-related genes, remain largely …
The m6A reader YTHDC1-mediated lncRNA CTBP1-AS2 m6A modification accelerates cholangiocarcinoma progression
Z Jin, Y Liu - Heliyon, 2023 - cell.com
Background Cholangiocarcinoma (CCA) is a serious malignancy originating from the bile
ducts and the second most common primary liver cancer. Long non-coding RNA (lncRNA) is …
ducts and the second most common primary liver cancer. Long non-coding RNA (lncRNA) is …
Cuproptosis-and m6A-Related lncRNAs for prognosis of hepatocellular carcinoma
Simple Summary Hepatocellular carcinoma (HCC) is known for its poor prognosis, but the
markers for prognosis still remain unclear to date. This study focused on the long non-coding …
markers for prognosis still remain unclear to date. This study focused on the long non-coding …
METTL3 and METTL14-mediated N6-methyladenosine modification of SREBF2-AS1 facilitates hepatocellular carcinoma progression and sorafenib resistance …
X Wu, M Zeng, Y Wei, R Lu, Z Huang, L Huang… - Scientific Reports, 2024 - nature.com
As the most prevalent epitranscriptomic modification, N6-methyladenosine (m6A) shows
important roles in a variety of diseases through regulating the processing, stability and …
important roles in a variety of diseases through regulating the processing, stability and …
Beta2-Microglobulin as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram
Q Lin, Z Jiang, D Mo, F Liu, Y Qin, Y Liang… - Journal of …, 2023 - Taylor & Francis
Background Accurate prognosis is crucial for improving hepatocellular carcinoma (HCC)
patients, clinical management, and outcomes post-liver resection. However, the lack of …
patients, clinical management, and outcomes post-liver resection. However, the lack of …
[HTML][HTML] Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells
Z Dou, XT Ma, MN Piao, JP Wang… - Translational Cancer …, 2024 - ncbi.nlm.nih.gov
Abstract N6-methyladenosine (m6A) is one of the most common internal modifications in
eukaryotic RNA. The presence of m6A on transcripts can affect a series of fundamental …
eukaryotic RNA. The presence of m6A on transcripts can affect a series of fundamental …
[引用][C] Xianjian Wu, Min Zeng 2, 5, Yunyu Wei 2, Rongzhou Lu 2, Zheng Huang 2, Lizheng Huang 2
Y Huang, Y Lu, W Li, H Wei, J Pu - Scientific Reports, 2024